🔎 Trials Near Me

Akèy › Kansè nan tete › New Hampshire

Etid klinik pou Kansè nan tete nan New Hampshire

16 etid pou Kansè nan tete ap chèche patisipan nan sit nan New Hampshire.

Tèks ofisyèl etid la (Anglè)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • New Hampshire Oncology Hematology PA-Concord, Concord
  • Solinsky Center for Cancer Care, Manchester
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

  • Dana-Farber/New Hampshire Oncology-Hematology, Londonderry
Ap rekriteFaz 3
Laj 60 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06377852

Testing a Mammography Decision Intervention in a Rural Setting

  • Cheshire Medical Center, Keene
  • New London Hospital Primary Care, New London
  • Newport Health Center, Newport
Ap rekrite
Laj 39 a 49 · Fanm · Mizajou Sep 24, 2026 · NCT06522568

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

  • Clinical Trial Site, Lebanon
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Dartmouth-Hitchcock Medical Center, Lebanon
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07174336

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • Dartmouth Hitchcock Medical, Lebanon
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06253871

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Dartmouth Hitchcock Medical Center, Lebanon
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

Pilot SMART of a Remotely Delivered, Physical Activity Intervention for Breast Cancer Survivors

  • Dartmouth-Hitchcock Clinic, Lebanon
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07706556

ATEMPT 2.0: Adjuvant T-DM1 vs TH

  • NH Oncology-Hematology, PA - Payson Center for Cancer Care, Concord
  • Dana-Farber Cancer Insitute at Londonderry Hospital, Londonderry
  • Solinsky Center for Cancer Care (NH Oncology-Hematology, PA), Manchester
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04893109

MRg-NIRS Imaging System Breast Cancer Trial

  • Dartmouth-Hitchcock Medical Center, Lebanon
Ap rekrite
Laj 18 a 83 · Fanm · Mizajou Jun 23, 2026 · NCT06400563

A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation

  • Dartmouth-Hitchcock Clinic, Lebanon
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT06258993

STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)

  • Dartmouth-Hitchcock Medical Center, Lebanon
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou May 5, 2026 · NCT05716516

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Ap rekriteFaz 3
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

  • Dartmouth Cancer Center/Dartmouth-Hitchcock Medical Center, Lebanon
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT02926690

Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients

  • Dartmouth Cancer Center, Lebanon
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 12, 2026 · NCT07071038

Estradiol Plus Olaparib for Breast Cancer (PHOEBE)

  • Dartmouth Cancer Center, Lebanon
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Nov 20, 2025 · NCT05900895

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.